Chloramphenicol, which can block attachment of mRNA to ribosomes and inhibit protein synthesis (1) (2) (3) , has reportedly ameliorated the symptoms of parkinsonism (4-6). L-Dopa, which is widely used to ameliorate these same symptoms (7), can also inhibit cerebral protein synthesis (8) , perhaps by deaggregating cerebral polyribosomes (9, 10) . Sustained restriction of protein intake, furthermore, has progressively potentiated the cerebral effects of i-dopa in patients with parkinsonism (l1). One might thus surmise that diminution of cerebral protein synthesis, might promote dopaminergic activity as well as the effects of -dopa. The opposite suggestion might, however, emerge from the following. Nicotinamide, an inhibitor of tRNA transmethylase (12) , has blocked the cerebral effects of -dopa (13) , while such effects were minimal in the mouse mutant pallid, in which cerebral uptake of large neutral amino acids was slow (14) . It was, thus, interesting to determine whether any of these suggestions was germane.
Three inhibitors of protein synthesis, acting on ribosomes by different mechanisms and given by different routes, are shown to-diminish cerebral protein synthesis in mice. Each induced a diminution of behavioral responses to dopaminergic and cholinergic drugs, which, seen together with some neurochemical findings, suggested that the reactions of dopaminergic and of eholinergic neurons had been 'diminished: Con- versely, increasing cerebral protein synthesis (15) 0.56$ All chemicals were given intraperitoneally except those marked (*), which were given orally, and (t), which were given intracerebrally. = P < 0.001.
caudectomy was successful only if curving of the body to the right was evoked by apomorphine (Merck & Co., 2 ,ug/g) given intraperitoneally (i.p.) (17) . Before treatment with levodopa (Nutritional Biochem. Corp., 0.4 ,g/g, i.p.), the mice were treated with water, with an inhibitor, with an inactive analog of an inhibitor, or with poly(I) -poly(C) as specified below. Regimens. The pretreatment regimens shown in Tables 1, 2 , 3, and 4 were formulated after we determined the following: (1) doses avoiding lethality and behavioral changes; (2) routes of administration permitting significant diminution of whole brain protein synthesis (tested in vitro); and (3) an effective interval between pretreatment and testing. For example, chloramphenicol (Parke, Davis) was tolerated only orally. Cycloheximide (Nutritional Biochemicals Corp.) and isocycloheximide, given both i.p. and intracerebrally (i.c.), produced brief hyperactivity, different from that produced by levodopa (18) , necessitating delay in injecting the latter. Puromycin (Nutritional Biochemicals Corp.) was active only i.c. (19) . A tolerated volume of injections i.c. was 20 ,u.
Artificial double-stranded RNA [poly(J) -poly(C) I was obtained from Miles Laboratories in 25-mg or 5-mg vials and from Schwarz/Mann Laboratory in 5-mg vials. There was significant variance in potency among poly(I) -poly(C) preparations: those with the highest extinction coefficients (determined between 220 and 310 nm in a Carrie spectrophotometer) seemed to yield higher cerebral effects.
Inhibition of Cerebral Protein Synthesis. Groups of at least six mice were given either water or an inhibitor, using the doses and routes shown in the Tables. Whole brains were handled according to Whur and Weatherhead (20) Analyses of Brains. Analyses for dopa and dopamine were done in whole brain at the peak of behavioral changes (17) .
Measurements of aromatic-L amino-acid decarboxylase (EC 4.1.1.28) (23) had to be modified to bring upon termination of the enzymatic reaction, initiation of the microdiffusion of the "4CO2 [evolved by the decarboxylation of "4CO-labeled d,l-dopa (New England Nuclear Corp.)], and recovery of "4CO2. For this, 2 ml of 10% (w/v) H2S04 were added to 2.0 ml of reaction mixture, and the effectiveness was proven by analyzing the CO2 trapped (0.2 ml of NCS solution, Amersham Searle on filter paper) in the manner developed earlier (24) .
Adenylate cyclase (EC 4.6.1.1) activities were measured in the homogenized caudates from groups of mice given either water or chloramphenicol (1.5 mg/g) by gastric intubation twice at 1.5-hr intervals and decapitated 90 min later. The caudate nuclei from two animals were homogenized in 0.5 ml of the Tris-maleate buffer recommended by Kebabian et al. (25) . Each homogenate (0.4 ml) was equilibrated at 300, and 50 ,ul of water were added to the control samples. Either 5 or 10 MM dopamine -HC1 (Calbiochem) was added to the dopamine-stimulated samples. The reaction was initiated with ATP (0.5 mM in 50 Ml) and was stopped 2.5 min later in a boiling-water bath. The samples were then centrifuged at 40 for 2 min at 1500 X g, and the supernatant was kept frozen until analyzed for cyclic AMP with the Gilman test kit (Boeringer-Mannheim) (26, 27) . This same procedure was followed with animals receiving poly(I) * poly(C). 
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All chemicals were given intraperitoneally except those marked (*), which were given orally, and (t), which were given intracerebrally. Behavioral Scores. In the caudectomized mice the effects of muzzle, muscle jerks, jumping, and stereotyped movements; L-dopa were assessed by their postural changes. The intact and (2) by measuring motor activities (3 mice per point) in mice were studied as follows: (1) by grading, often blindly, an Animex motor activity meter (28) , an easier but less conthe following items in each mouse as 0-3 and summing the vincing method. The effects of L-dopa were potentiated in scores: hyperactivity, panting, piloerection, salivation, red some experiments by adding to the pretreatment regimen the 74.62t
Confirmation with an automatic activity meter of some observations made with behavioral scoring. All chemicals were given intraperitoneally except those marked (*), which were given orally, and (t), which were given intracerebrally. 
OBSERVATIONS
The caudectomized mice (6 per group) failed to show postural changes due to saline, cycloheximide, puromycin, or chloramphenicol given by the routes shown in Table 1 . When, however, these pretreatments were followed by the injections of ibdopa, all the saline-treated animals developed the characteristic curving, but none of the inhibitor-treated ones did. In intact mice (Tables 2, 3 , and 4) the following were found: (1) All inhibitors of protein synthesis diminished the behavioral effects of i.-dopa regardless of the end point used, even when the i-dopa was potentiated with a-methyldopa hydrazine (13) . (2) The degree of diminution was roughly the same for each inhibitor and with each measurement. (3) The individual items of the behavioral scores were diminished almost en bloc. (4) Analogs that do not inhibit protein synthesis were inactive: 6-dimethylaminopurine (K & K) for puromycin (29) , Lechloramphenicol (Parke, Davis Co.) for chloramphenicol, and isocycloheximide (Dow Chemical Co.) for cycloheximide (18) .
We suspected at first (13) that the inhibitors might have diminished the enzyme aromatic iamino-acid decarboxylase and, thus, the cerebral synthesis of dopamine from L-dopa. Decarboxylase activity was, therefore, measured on homogenates of whole brains from six chloramphenicol-and six saline-treated mice, the latter being tested with and without the addition of chloramphenicol (25,sg/ml) to the final reaction mixture. Since the reaction velocity remained unaffected, it appeared that the cerebral synthesis of dopamine had remained intact. Whole brains were therefore analyzed for dopa and dopamine from the following groups (6 animals each): (1) saline-treated; (2) levodopa-treated; (3) chloramphenicoltreated, and (4) 
P<0.00o
..( 6) amphenicol and the other inhibitors should also diminish the animals' reactions to the dopaminergic drug, apomorphine (13). All chemicals were given intraperitoneally except those marked (*), which were given orally, and (t), which were given intracerebrally. = decrease from control; t = increase from control; -= no change; ND = not done; 0 = no observable effect; A = hyperactivity; + = positive effect.
The means and standard errors of the effects of apomorphine (Table 3) , scored by a system different from that used for levodopa (30) , were diminished by cycloheximide, chloramphenicol, and puromycin in intact mice. Caudectomized mice treated with the apomorphine (2 jsg/g, i.p.) failed to show the characteristic conjugate deviation if pretreated with the chloramphenicol or the cycloheximide (Table 1) . These results again suggested that the inhibitors of protein synthesis had lowered the reactivity of dopaminergic receptors, and that cholinergic ones should be examined as well.
When the muscarinic cholinergic drug, oxotremorine (Nutritional Biochemicals Corp.) (31) , was injected (0.2 ,ug/g, i.p.) into caudectomized mice, these developed a marked curving in the direction opposite to the caudectomy (opposite to that induced by L-dopa and apomorphine) lasting for 2-3 hr, frequently interrupted by running in that direction. These phenomena were eliminated by pretreatment with chloramphenicol ( Table 1) . In intact mice, chloramphenicol given orally or cycloheximide given i.p. diminished or eliminated the responses, graded from 0-3, of tremor, opisthotonus, ataxia, panting, salivation, red muzzle, corkscrew tail, exophthalmus, and lacrymation induced by oxotremorine (0.2 sg/g, i.p.) in saline-pretreated controls. Intracerebral cycloheximide or puromycin diminished selectively and markedly tremor and opisthotonic posture ( Table 3 ). The sum of these findings supported the idea that the inhibitors of protein synthesis had diminished the reactivity of more than one class of cerebral receptors. If so, one should find evidence of the opposite by stimulating cerebral protein synthesis.
A proven stimulator of protein synthesis is the artificial double-stranded RNA, poly(I) * poly(C) (15) . Intraperitoneal injection (1.5 ug/g), oral administration (10 ,ug/g), and intracerebral injection (1.5,Ag/animal) of several preparations of poly(I) . poly(C) in intact or caudectomized mice was followed, respectively, 3 or 4 hr later by injection of dopa (0.2 or 0.4 mg/g), apomorphine (1 ug/g), N-propylaporphine (Sterling Winthrop Research Institute, 0.05,g/g), or oxotremorine (0.1 Mg/g). Pretreatment with poly(I) -poly(C) markedly hastened the onset of the behavioral responses while increasing their intensity and duration. These changes were reflected in the behavioral scores of intact mice and in the curving of unilaterally caudectomized ones (Tables 1, 2, and  3) . It thus became important to determine whether this increase or a decrease of reactivity would be reflected in the dopamine-activated production of cyclic AMP by homogenized caudate nuclei from appropriately pretreated donors (Fig. 1) .
DISCUSSION
The present experiments, summarized in Table 5 , show that three inhibitors of protein synthesis, given by routes permitting inhibition of cerebral protein synthesis, have reduced the behavioral effects of two dopaminergic drugs and of one muscarinic cholinergic one. Conversely, the artificial doublestranded RNA, poly(I) -poly(C), shown by Levy and Riley (15) to increase cerebral protein synthesis, has potentiated the behavioral effects of these drugs. The potentiation and the inhibition of the behavioral responses were accompanied by concordant effects on the dopamine-stimulated production of cyclic AMP from ATP in isolated, homogenized caudate nuclei obtained from mice pretreated with chloramphenicol, cycloheximide, poly(I) * poly(C), or water. This evidence, seen together with the absence of changes in cerebral decarboxylase and dopamine concentrations, indicates that changing the rate of cerebral protein synthesis changed the reactivity of neuronal receptors in the brain. A precise molecular hypothesis cannot be formulated because the common denominator among the inhibitors tested, namely, that they all produce inhibition of the 32S ribosomal subunit (3, 32) , might or might not explain how inhibitors acting by different molecular mechanisms had the same behavioral effects. The rapidity with which these phenomena were induced, however, argues that proteins having a rapid turnover are critical to the function of a variety of neuronal receptors.
